Biosyntia secures €11.5 million funding to produce biobased vitamin B7 at commercial-scale [Registered]

The Danish biotech start-up Biosyntia has secured €11.5 million in funding from a strong syndicate of capital investors to support the production of natural ingredients for use in beauty and nutrition products such as vitamins and antioxidants via a precision fermentation platform.… Login to continue